Search…

Lates News

06/11/2025

According to AI Quick News, Pacific Securities released a research report on November 6th, giving a "buy" rating to MicroPort Biologicals (688321.SH). The main reasons for the rating include: 1) The main endpoint data of debacarbazine (DEB) in the research is impressive; 2) Smooth progress in the clinical development of debacarbazine and zilucoplan. (Daily Economic News)

Latest

2 m ago

US stocks fluctuate | BeiGene (ONC.US) rises by more than 3%, third-quarter revenue exceeds 10 billion, raises 2025 performance guidance.

2 m ago

In the early trading on Thursday, the stock price of CoreWeave dropped by 6.5% in the US stock market. The company is about to announce its third-quarter financial report, and market expectations are that it will show rapid revenue growth but also losses. Investors are closely monitoring the company's order backlog, progress in financing, and power strategy after its acquisition of CoreScientific was rejected.

4 m ago

Source: Gazprom will receive a mineral extraction tax refund of 64 billion rubles between November 2026 and August 2028, with the expenses to be covered by other natural gas producers.

6 m ago

Analysts point out that the P/E ratio and other valuation indicators of the S&P 500 have reached levels close to those of the Internet bubble period.

7 m ago

According to reports, the U.S. Treasury Department has sanctioned individuals who "exploited loopholes in currency exchange facilities in Lebanon to facilitate Iran's transfer of tens of millions of dollars to Hezbollah by 2025."

See all latest